Notice of Meetings, 65321-65322 [2013-25833]
Download as PDF
Federal Register / Vol. 78, No. 211 / Thursday, October 31, 2013 / Notices
AHRQ’s estimate of burden (including
hours and costs) of the proposed
collection(s) of information; (c) ways to
enhance the quality, utility, and clarity
of the information to be collected; and
(d) ways to minimize the burden of the
collection of information upon the
respondents, including the use of
automated collection techniques or
other forms of information technology.
Comments submitted in response to
this notice will be summarized and
included in the Agency’s subsequent
request for OMB approval of the
proposed information collection. All
comments will become a matter of
public record.
Dated: October 1, 2013.
Richard Kronick,
Director.
[FR Doc. 2013–25839 Filed 10–30–13; 8:45 am]
BILLING CODE 4160–90–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Meeting of the National Advisory
Council for Healthcare Research and
Quality
Agency for Healthcare Research
and Quality (AHRQ), HHS.
ACTION: Notice of public meeting.
AGENCY:
In accordance with section
10(a) of the Federal Advisory Committee
Act, 5 U.S.C. App. 2, this notice
announces a meeting of the National
Advisory Council for Healthcare
Research and Quality.
DATES: The meeting will be held on
Friday, November 15, 2013, from 8:30
a.m. to 3:30 p.m.
ADDRESSES: The meeting will be held at
the Eisenberg Conference Center,
Agency for Healthcare Research and
Quality, 540 Gaither Road, Rockville,
Maryland 20850.
FOR FURTHER INFORMATION CONTACT:
Jaime Zimmerman, Designated
Management Official, at the Agency for
Healthcare Research and Quality, 540
Gaither Road, Rockville, Maryland
20850, (301) 427–1456. For press-related
information, please contact Alison Hunt
at (301) 427–1244.
If sign language interpretation or other
reasonable accommodation for a
disability is needed, please contact the
Food and Drug Administration (FDA)
Office of Equal Employment
Opportunity and Diversity Management
on (301) 827–4840, no later than Friday,
November 1, 2013. The agenda, roster,
mstockstill on DSK4VPTVN1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
19:21 Oct 30, 2013
Jkt 232001
and minutes are available from Ms.
Bonnie Campbell, Committee
Management Officer, Agency for
Healthcare Research and Quality, 540
Gaither Road, Rockville, Maryland
20850. Ms. Campbell’s phone number is
(301) 427–1554.
I. Purpose
The National Advisory Council for
Healthcare Research and Quality is
authorized by Section 941 of the Public
Health Service Act, 42 U.S.C. 299c. In
accordance with its statutory mandate,
the Council is to advise the Secretary of
the Department of Health and Human
Services and the Director, Agency for
Healthcare Research and Quality
(AHRQ), on matters related to AHRQ’s
conduct of its mission including
providing guidance on (A) Priorities for
health care research, (B) the field of
health care research including training
needs and information dissemination on
health care quality and (C) the role of
the Agency in light of private sector
activity and opportunities for public
private partnerships.
The Council is composed of members
of the public, appointed by the
Secretary, and Federal ex-officio
members specified in the authorizing
legislation.
II. Agenda
On Friday, November 15, 2013, there
will be a subcommittee meeting for the
National Healthcare Quality and
Disparities Report scheduled to begin at
7:30 a.m. The subcommittee meeting is
open the public. The Council meeting
will convene at 8:30 a.m., with the call
to order by the Council Chair and
approval of previous Council summary
notes. The meeting is open to the
public. The meeting will begin with the
AHRQ Director presenting an update on
current research, programs, and
initiatives. Following the Director’s
Update, the agenda includes updates on
Affordable Care Act implementation,
Patient Centered Outcomes Research
Institute and the subcommittee on
Strategic Direction. The final agenda
will be available on the AHRQ Web site
a www.AHRQ.gov no later than Friday,
November 8, 2013.
Richard Kronick,
AHRQ Director.
[FR Doc. 2013–25832 Filed 10–30–13; 8:45 am]
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Notice of Meetings
Agency for Healthcare Research
and Quality (AHRQ), HHS.
ACTION: Notice of Five AHRQ
Subcommittee Meetings.
AGENCY:
SUPPLEMENTARY INFORMATION:
BILLING CODE 4160–90–P
65321
The subcommittees listed
below are part of AHRQ’s Health
Services Research Initial Review Group
Committee. Grant applications are to be
reviewed and discussed at these
meetings. Each subcommittee meeting
will commence in open session before
closing to the public for the duration of
the meeting. These meetings will be
closed to the public in accordance with
5 U.S.C. App. 2 section 10(d), 5 U.S.C.
section 552b(c)(4), and 5 U.S.C.
552b(c)(6).
SUMMARY:
Note: Due to the Federal government
shutdown, AHRQ is republishing its Study
Section meetings with new dates. Please see
below.
See below for dates of meetings:
1. Healthcare Safety and Quality
Improvement Research (HSQR)
Date: October 23–24, 2013 (Open from
8:00 a.m. to 8:30 a.m. on October 23
and closed for remainder of the
meeting)
2. Healthcare Effectiveness and
Outcomes Research (HEOR)
Date: October 28, 2013 (Open from
8:30 a.m. to 9:00 a.m. on October 28
and closed for remainder of the
meeting)
3. Health Care Research and Training
(HCRT) (Telephone Conference
Call)
Date: October 30, 2013 (Open from
8:00 a.m. to 8:30 a.m. on October 30
and closed for remainder of the
meeting)
4. Health System and Value Research
(HSVR)
Date: October 31, 2013 (Open from
8:00 a.m. to 8:30 a.m. on October 31
and closed for remainder of the
meeting)
5. Healthcare Information Technology
Research (HITR)
Date: October 31–November 1, 2013
(Open from 8:00 a.m. to 8:30 a.m.
on October 31 and closed for
remainder of the meeting)
ADDRESSES: Meetings of Healthcare
Safety and Quality Improvement
Research (HSQR), Healthcare
Effectiveness and Outcomes Research
(HEQR), Health System and Value
Research (HSVR), and Health System
DATES:
E:\FR\FM\31OCN1.SGM
31OCN1
65322
Federal Register / Vol. 78, No. 211 / Thursday, October 31, 2013 / Notices
and Value Research (HSVR) will take
place at: Hyatt Regency Hotel Bethesda,
One Metro Center, Bethesda, MD 20814.
Conference Call of Health Care
Research and Training (HCRT) meeting
will take place at: AHRQ, (Conference
Room TBD), 540 Gaither Road,
Rockville, MD 20850.
(to
obtain a roster of members, agenda or
minutes of the non-confidential portions
of the meetings.)
Mrs. Bonnie Campbell, Committee
Management Officer, Office of
Extramural Research Education and
Priority Populations, AHRQ, 540
Gaither Road, Suite 2000, Rockville,
Maryland 20850, Telephone (301) 427–
1554.
FOR FURTHER INFORMATION CONTACT:
In
accordance with section 10(a)(2) of the
Federal Advisory Committee Act (5
U.S.C. App. 2), AHRQ announces
meetings of the scientific peer review
groups listed above, which are
subcommittees of AHRQ’s Health
Services Research Initial Review Group
Committee. Each subcommittee meeting
will commence in open session before
closing to the public for the duration of
the meeting. The subcommittee
meetings will be closed to the public in
accordance with the provisions set forth
in 5 U.S.C. App. 2 section 10(d), 5
U.S.C. 552b(c)(4), and 5 U.S.C.
552b(c)(6) The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Agenda items for these meetings are
subject to change as priorities dictate.
SUPPLEMENTARY INFORMATION:
Dated: October 24, 3013.
Richard Kronick,
AHRQ Director.
[FR Doc. 2013–25833 Filed 10–30–13; 8:45 am]
BILLING CODE 4160–90–P
Background and Brief Description
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Steady increases in the rate and
severity of Clostridium difficile
infection (CDI) indicate a clear need to
conduct longitudinal assessments to
continue to monitor changes in CDI
epidemiology, including changes in risk
factors for disease, as well as increases
The surveillance population will consist
of persons residing in the catchment
area of the participating Emerging
Infections Program (EIP) sites who are 1
year of age or older. This surveillance
poses no more than minimal risk to the
study participants as there will be no
interventions or modifications to the
care study participants receive. EIP
surveillance personnel will perform
active case finding from laboratory
reports of stool specimens testing
positive for C. difficile toxin and
abstract data on cases using a
standardized case report form. For a
subset of cases (e.g., communityassociated C. difficile cases) sites will
administer a health interview.
CDC requests Office of Management
and Budget (OMB) extension of
standardized data collection for an
additional three years. The
epidemiology of C. difficile continues to
evolve and incidence of disease is still
high with no significant declines being
observed. Continuing to understand
what put persons at risk for C. difficile
in the community is critical to inform
prevention strategies. There are no
changes in the burden estimates or data
collection instruments from what is
shown in the current inventory.
A total of 600 individuals who
develop CDI will be contacted for a
telephone interview annually and of
those it is estimated that 500 will meet
study inclusion criteria. The interview
screening is estimated to take 5 minutes
and the full telephone interview is
estimated to take 40 minutes. Therefore,
the total estimated annualized burden
for this data collection is estimated to be
383 hours.
There are no costs to the respondents
other than their time.
Centers for Disease Control and
Prevention
[60Day–14–0892]
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–7570 or send
comments to LeRoy Richardson, 1600
Clifton Road, MS–D74, Atlanta, GA
30333 or send an email to omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
Clostridium difficile Infection (CDI)
Surveillance (0920–0892, Expiration
07/31/2014)—Extension—National
Center for Emerging and Zoonotic
Infectious Diseases (NCEZID), Centers
for Disease Control and Prevention
(CDC).
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Number of
responses per
respondent
Avg. burden
per response
(in hrs.)
Total burden
(in hrs.)
mstockstill on DSK4VPTVN1PROD with NOTICES
Type of respondents
Form name
Persons in the community infected
with C. difficile.
Screening Form ................................
600
1
5/60
50
Telephone Interview .........................
500
1
40/60
333
...........................................................
........................
........................
........................
383
Total ...........................................
VerDate Mar<15>2010
19:21 Oct 30, 2013
Jkt 232001
PO 00000
Frm 00059
Fmt 4703
Sfmt 4703
E:\FR\FM\31OCN1.SGM
31OCN1
Agencies
[Federal Register Volume 78, Number 211 (Thursday, October 31, 2013)]
[Notices]
[Pages 65321-65322]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-25833]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
Notice of Meetings
AGENCY: Agency for Healthcare Research and Quality (AHRQ), HHS.
ACTION: Notice of Five AHRQ Subcommittee Meetings.
-----------------------------------------------------------------------
SUMMARY: The subcommittees listed below are part of AHRQ's Health
Services Research Initial Review Group Committee. Grant applications
are to be reviewed and discussed at these meetings. Each subcommittee
meeting will commence in open session before closing to the public for
the duration of the meeting. These meetings will be closed to the
public in accordance with 5 U.S.C. App. 2 section 10(d), 5 U.S.C.
section 552b(c)(4), and 5 U.S.C. 552b(c)(6).
Note: Due to the Federal government shutdown, AHRQ is
republishing its Study Section meetings with new dates. Please see
below.
DATES: See below for dates of meetings:
1. Healthcare Safety and Quality Improvement Research (HSQR)
Date: October 23-24, 2013 (Open from 8:00 a.m. to 8:30 a.m. on
October 23 and closed for remainder of the meeting)
2. Healthcare Effectiveness and Outcomes Research (HEOR)
Date: October 28, 2013 (Open from 8:30 a.m. to 9:00 a.m. on October
28 and closed for remainder of the meeting)
3. Health Care Research and Training (HCRT) (Telephone Conference Call)
Date: October 30, 2013 (Open from 8:00 a.m. to 8:30 a.m. on October
30 and closed for remainder of the meeting)
4. Health System and Value Research (HSVR)
Date: October 31, 2013 (Open from 8:00 a.m. to 8:30 a.m. on October
31 and closed for remainder of the meeting)
5. Healthcare Information Technology Research (HITR)
Date: October 31-November 1, 2013 (Open from 8:00 a.m. to 8:30 a.m.
on October 31 and closed for remainder of the meeting)
ADDRESSES: Meetings of Healthcare Safety and Quality Improvement
Research (HSQR), Healthcare Effectiveness and Outcomes Research (HEQR),
Health System and Value Research (HSVR), and Health System
[[Page 65322]]
and Value Research (HSVR) will take place at: Hyatt Regency Hotel
Bethesda, One Metro Center, Bethesda, MD 20814.
Conference Call of Health Care Research and Training (HCRT) meeting
will take place at: AHRQ, (Conference Room TBD), 540 Gaither Road,
Rockville, MD 20850.
FOR FURTHER INFORMATION CONTACT: (to obtain a roster of members, agenda
or minutes of the non-confidential portions of the meetings.)
Mrs. Bonnie Campbell, Committee Management Officer, Office of
Extramural Research Education and Priority Populations, AHRQ, 540
Gaither Road, Suite 2000, Rockville, Maryland 20850, Telephone (301)
427-1554.
SUPPLEMENTARY INFORMATION: In accordance with section 10(a)(2) of the
Federal Advisory Committee Act (5 U.S.C. App. 2), AHRQ announces
meetings of the scientific peer review groups listed above, which are
subcommittees of AHRQ's Health Services Research Initial Review Group
Committee. Each subcommittee meeting will commence in open session
before closing to the public for the duration of the meeting. The
subcommittee meetings will be closed to the public in accordance with
the provisions set forth in 5 U.S.C. App. 2 section 10(d), 5 U.S.C.
552b(c)(4), and 5 U.S.C. 552b(c)(6) The grant applications and the
discussions could disclose confidential trade secrets or commercial
property such as patentable material, and personal information
concerning individuals associated with the grant applications, the
disclosure of which would constitute a clearly unwarranted invasion of
personal privacy.
Agenda items for these meetings are subject to change as priorities
dictate.
Dated: October 24, 3013.
Richard Kronick,
AHRQ Director.
[FR Doc. 2013-25833 Filed 10-30-13; 8:45 am]
BILLING CODE 4160-90-P